Vytrus Biotech buys back stock in block deal for EUR 1.98 million

• Vytrus bought back 381,814 shares in a block trade at EUR 5.17 each, valuing the transaction at EUR 1.98 million.
• The shares were held by its US and Canada distributor under a 2021 investment deal and a 2024 capital increase.
• Funding came entirely from internal resources.
• Vytrus also signed a new exclusive supply and distribution agreement for the US and Canada.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vytrus Biotech SA published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.